共 51 条
Interactions of α-, β-, and θ-Defensins with Influenza A Virus and Surfactant Protein D
被引:118
作者:
Doss, Mona
White, Mitchell R.
Tecle, Tesfaldet
Gantz, Donald
[2
]
Crouch, Erika C.
[3
]
Jung, Grace
[4
]
Ruchala, Piotr
[4
]
Waring, Alan J.
[4
]
Lehrer, Robert I.
[4
]
Hartshorn, Kevan L.
[1
]
机构:
[1] Boston Univ, Sch Med, Dept Med, Evans Biomed Res Ctr, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Biophys, Boston, MA 02118 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63104 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
关键词:
HUMAN NEUTROPHIL DEFENSINS;
INNATE IMMUNITY;
PULMONARY COLLECTINS;
ALVEOLAR MACROPHAGES;
OPSONIC ACTIVITY;
INFECTION;
BINDING;
LUNG;
RETROCYCLIN;
PEPTIDE;
D O I:
10.4049/jimmunol.0804049
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
We have reported that the alpha-defensins human neutrophil peptides (HNP)-1 and HNP-2 neutralize and aggregate influenza A virus (IAV) and promote uptake of IAV by neutrophils. These alpha-defensins were also shown to bind to surfactant protein (SP)-D and reduce its antiviral activity. In this study, we examined retrocyclin (RC)1 and RC2, humanized versions of the antiviral theta-defensins found in the leukocytes of certain nonhuman primates. RC1 was just as effective as HNP-1-3 in neutralizing IAV, and RC2 and RC101 (an analog of RC1) were more effective. In contrast, human beta-defensins (HBDs) showed less neutralizing activity. Human defensins 5 and 6 (mainly produced by intestinal Paneth cells) had viral neutralizing activity similar to HNP-1-3. Like HNP-1-3, RCs induced viral aggregation and promoted the uptake of IAV by neutrophils. We used surface plasmon resonance to evaluate binding of defensins to SP-D. HBDs, HD6, and HNP-4 bound minimally to SP-D. HNP-1-3 and RCs bound SP-D with high affinity; however, unlike HNP-1 and HNP-2, RCs did not inhibit SP-D antiviral activity. HBDs also did not inhibit antiviral activity of SP-D. Given their strong neutralizing activity and compatibility with SP-D, RCs may provide attractive prototypes for designing therapeutics that can prevent or treat respiratory infections caused by IAV. The Journal of Immunology, 2009, 182: 7878-7887.
引用
收藏
页码:7878 / 7887
页数:10
相关论文